florbetaben   Click here for help

GtoPdb Ligand ID: 7769

Synonyms: [18F]BAY 94-9172 [1] | AV-1 [2] | BAY 94-9172 [2] | Neuraceq®
Approved drug  Ligand is labelled  Ligand is radioactive
florbetaben is an approved drug (EMA & FDA (2014))
Compound class: Synthetic organic
Comment: Florbetaben F18 is the third PET (positron-emission tomography) reagent approved to identify amyloid-β (Aβ) as a diagnostic biomarker in the brains of patients with Alzheimer's disease (AD) [1]. Flutemetamol and florbetapir are the two other PET reagents approved for Aβ detection. These diagnostic tools allow direct and non-invasive in vivo visualisation and quantification of Aβ.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 39.72
Molecular weight 359.19
XLogP 4.46
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FCCOCCOCCOc1ccc(cc1)C=Cc1ccc(cc1)NC
Isomeric SMILES [18F]CCOCCOCCOc1ccc(cc1)/C=C/c1ccc(cc1)NC
InChI InChI=1S/C21H26FNO3/c1-23-20-8-4-18(5-9-20)2-3-19-6-10-21(11-7-19)26-17-16-25-15-14-24-13-12-22/h2-11,23H,12-17H2,1H3/b3-2+/i22-1
InChI Key NCWZOASIUQVOFA-FWZJPQCDSA-N
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
amyloid β Primary target of this compound Hs None Binding 8.6 pKi - 2
pKi 8.6 (Ki 2.22x10-9 M) PET imaging agent for Aβ plaques in brain [2]
Description: Inhibition of 18F-AV-45 binding to Aβ plaques in postmortem AD brain homogenates.